Integrated Prevention of HIV Risk and Intimate Partner Violence Among Adolescents in South Africa
NCT ID: NCT03179982
Last Updated: 2025-06-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-02-01
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing the Efficacy of Safe South Africa
NCT06750107
Effect of HIV/STD Risk Reduction Program on South African Adolescents
NCT00559403
Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents
NCT00640653
Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men
NCT01490359
HIV and STD Prevention for High-Risk, Inner-City, African American Youth
NCT00353405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Male adolescents (15-17 years) will be randomly allocated to an intervention arm based on permuted blocked randomization. The intervention arm will receive the HIV-IPV intervention called Safe South Africa.
Safe South Africa is a group-based, facilitated behavioral intervention for prevention of HIV risk and IPV perpetration specifically tailored for male adolescents. The behavioral intervention is comprised of 2-hour sessions, held once a week for a total of two weeks.
Safe South Africa
Core components of the Safe South Africa intervention include the following:
* Theory driven, best-evidence intervention approaches to adolescent HIV prevention
* Linkages between HIV and IPV
* Victim Empathy
* Healthy Norms Regarding Masculinity
* Bystander Intervention Skills
Control
Male adolescents (15-17 years) will be randomly allocated to a control arm based on permuted blocked randomization. The control arm will consist of ordinary usual care. The ordinary usual care condition will consist of a packet of existing available brochures on HIV and other sexually transmitted diseases including testing, prevention, and treatment; IPV prevention and intervention; and places to access prevention, care, and support for these outcomes and related health outcomes.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Safe South Africa
Core components of the Safe South Africa intervention include the following:
* Theory driven, best-evidence intervention approaches to adolescent HIV prevention
* Linkages between HIV and IPV
* Victim Empathy
* Healthy Norms Regarding Masculinity
* Bystander Intervention Skills
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 15-17 years of age, inclusive of 15 and 17
Exclusion Criteria
* adolescent does not provide assent
15 Years
17 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Research Council, South Africa
OTHER
Rhode Island Hospital
OTHER
Brown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Caroline Kuo
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South African Medical Research School
Cape Town, , South Africa
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.